Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: A prospective study

Blood Purification

Volumn 25, Issue 4, 2007, Pages 316-323

  Nurmohamed, S Azam ^a   Vervloet, Marc G ^a   Girbes, Armand R J ^a   Ter Wee, Pieter M ^a   Groeneveld, A B Johan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Continuous venovenous hemofiltration; Filter life; Regional anticoagulation; Trisodium citrate

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM GLUBIONATE; CITRIC ACID;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; COHORT ANALYSIS; CONTINUOUS HEMOFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UREMIA;

AGED; ANTICOAGULANTS; CALCIUM; CITRATES; COHORT STUDIES; EQUIPMENT FAILURE; FEMALE; HEMOFILTRATION; HEMORRHAGE; HEMORRHAGIC DISORDERS; HUMANS; INTENSIVE CARE; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SOLUTIONS;

EID: 34548850399     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107045     Document Type: Article

References (27)

1. Kellum JA, Angus DC, Johnson JP, et al: Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002;28:29-37.
2. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Continuous is not continuous: the incidence and impact of circuit 'downtime' on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003;29:575-578.
3. Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int Suppl 1993;41:S237-S244.
4. Van de Wetering J, Westendorp RG, Van der Hoeven JG, Stolk B, Feuth JD, Chang PC: Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996:7:145-150.
5. Vos P, Speelberg B: Survival of the artificial kidney during systemic versus regional anticoagulation with heparin for continuous veno-venous hemofiltration in the intensive care unit. NTvIC 2001;16:266-272.
6. Morabito S, Guzzo I, Solazzo A, Muzi L, Luciano R, Pierucci R: Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding. J Nephrol 2003;16:566-571.
7. Kaplan AA, Petrillo R: Regional heparinization for continuous arteriovenous hemofiltration. ASAIO Trans 1987;33:312-315.
8. Schwartz R, Port F: Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin. Kidney Int 1997;16:513-518.
9. Paganini EP: Slow continuous hemofiltration and slow continuous ultrafiltration. ASAIO Trans 1988;34:63-66.
10. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P: Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004;30:260-265.
11. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C: Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 2002;28:1419-1425.
12. Kutsogiannis DJ, Mayers I, Chin WDN, Gibney RTN: Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 2000;35:802-811.
13. Thoenen M, Schmid ER, Binswanger U, Schuepbach R, Aerne D, Schmidlin D: Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Wien Klin Wochenschr 2002;114:108-114.
14. Uchino S, Fealy N, Baldwin I, Morimatsu I, Bellomo R: Continuous venovenous hemofiltration without anticoagulation. ASAOI J 2004;50:76-80.
15. Tan HK, Baldwin I, Bellomo R: Continuous venovenous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000;26:1652-1657.
16. Mehta RL, McDonald BR, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis: an update after 12 months. Contrib Nephrol. Basel, Karger, 1991, vol 93, pp 210-214.
17. Mehta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-981.
18. Silverstein FJ, Oster JR, Perez GO, Materson BJ, Lopez RA, Al-Reshaid K: Metabolic alkalosis induced by regional citrate hemodialysis. ASAIO Trans 1989;35:22-25.
19. Meier-Kriesche HU, Finkel KW, Gitomer JJ, DuBose TD: Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 1999;33:1-4.
20. Morgera S, Scholle C, Voss G, et al: Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract 2004;97:c131-c136.
21. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999;55:1991-1997.
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985;13;818-829.
23. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754-1758.
24. Hofmann RM, Maloney C, Ward DM, Becker BN: A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration. Ren Fail 2002;24:325-335.
25. Brophy PD, Somers MJG, Baum MA, et al: Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy. Nephrol Dial Transplant 2005;20:1416-1421.
26. Morita Y, Johnson RW, Dorn RE, Hall DS: Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 1961;42:32-43.
27. Kramer L, Bauer E, Joukhadar C, et al: Citrate pharmacokinetics and metabolism in cirrhotic and non-cirrhotic critically ill patients. Crit Care Med 2003;31:2450-2455.